1. 115 Impact of siponimod on myelination across SPMS subgroups: post-hoc analysis from EXPAND MRI substudy. Issue 6 (27th May 2022) Authors: Arnold, DL; Bar-Or, A; Cree, BAC; Giovannoni, G; Gold, R; Vermersch, P; Piani-Meier, D; Arnould, S; Kappos, L Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 118 Sustained reduction of disability and cognitive decline with long-term siponimod in EXPAND active SPMS patients. Issue 6 (27th May 2022) Authors: Giovannoni, G; Kappos, L; Fox, RJ; Vermersch, P; Cree, BAC; Benedict, RHB; Bar-Or, A; Piani-Meier, D; Ritter, S Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. Issue 10 (October 1992) Authors: Scheltens, P; Leys, D; Barkhof, F; Huglo, D; Weinstein, H C; Vermersch, P; Kuiper, M; Steinling, M; Wolters, E C; Valk, J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 55:Issue 10(1992) Page Start: 967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions. Issue 5 (1st November 2000) Authors: Stojkovic, T; de Seze, J; Maurage, C-A; Rose, C; Hache, J-C; Vermersch, P Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 69:Issue 5(2000) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. Issue 3 (March 1993) Authors: Caparros-Lefebvre, D; Blond, S; Vermersch, P; Pécheux, N; Guieu, J D; Petit, H Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 56:Issue 3(1993) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients. Issue 12 (16th November 2009) Authors: Bourteel, H; Vermersch, P; Cuisset, J-M; Maurage, C-A; Laforet, P; Richard, P; Stojkovic, T Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 80:Issue 12(2009) Page Start: 1405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?. Issue 1 (January 1991) Authors: Leys, D; Pruvo, J P; Parent, M; Vermersch, P; Soetaert, G; Steinling, M; Delacourte, A; Défossez, A; Rapoport, A; Clarisse, J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 54:Issue 1(1991) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease. Issue 6 (1st June 1998) Authors: Vuillaume, I; Vermersch, P; Destée, A; Petit, H; Sablonnière, B Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 64:Issue 6(1998) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hemifacial spasm due to pontine infarction. Issue 11 (November 1991) Authors: Vermersch, P; Petit, H; Marion, M H; Montagne, B Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 54:Issue 11(1991) Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. High‐affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. (10th February 2015) Authors: Oxombre, B; Lee‐Chang, C; Duhamel, A; Toussaint, M; Giroux, M; Donnier‐Maréchal, M; Carato, P; Lefranc, D; Zéphir, H; Prin, L; Melnyk, P; Vermersch, P Journal: British journal of pharmacology Issue: Volume 172:Number 7(2015:Apr.) Page Start: 1769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗